Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Bicalutamide and Goserelin Variant #01 | — | R 8 166 | 84d | — | — | — | — | 2 |
Degarelix monotherapy Variant #01 | — | R 7 595 | 84d | — | — | — | — | — |
Flutamide and Goserelin Variant #01 | — | R 3 653 | 28d | — | ~69.6 mo | — | — | 1 |
Leuprolide monotherapy Variant #01 | — | R 2 266 | 90d | — | — | — | — | 2 |
ADT Variant #01 Partial | — | — | — | — | — | — | — | 1 |
5 of 5 regimens shown